Abstract: Structural modifications of the front line antitubercular drug isoniazid provide lipophilic adaptations of the drug in which the hydrazide moiety of isoniazid is replaced by 1,3,4-oxadiazole heterocycles to eliminate in vivo acetylation by arylamine N-acetyltransferase, which results in the formation of inactive acetylated drug. In the present study, a series of sixteen oxadiazole derivatives were synthesized and characterized by IR, 1 H-NMR, 13 C-NMR and mass spectral studies. All the synthesized compounds were evaluated for their antimicrobial activity by broth dilution method against two Gram-positive bacterial strains (Bacillus subtilis and Staphylococcus aureus), two Gram-negative bacterial strains (Pseudomonas aeruginosa and Escherichia coli) and two fungal strains (Candida albicans and Aspergillus niger). The minimum inhibitory concentrations of the compounds were in the range of 1.56-50 µg ml -1 against the bacterial and fungal strains. The results revealed that all the synthesized compounds have a significant biological activity against the tested microorganisms. Among the synthesized derivatives 4g, 4h, 4m and 4p were found to be the most effective antimicrobial compounds.
INTRODUCTION
One of the key objectives of organic and medicinal chemists is to design and synthesize molecules having potent therapeutic values. 1 The rapid development of resistance to existing antimicrobial drugs generates a serious challenge to the scientific community. Consequently, there is a vital need for the development of new antimicrobial agents having potent activity against the resistant microorga- nism. [2] [3] [4] [5] 1,3,4-Oxadiazoles have played an important role in medicinal chemistry, pesticide chemistry, polymer science and they are the building blocks in the construction of new molecular systems for biologically active molecules. 6 Many 1,3,4-oxadiazoles display a remarkable biological activity, such as antimicrobial, 7, 8 anti-HIV, 9 antitubercular, 10 antimalarial, 11 analgesic, 12 anti-inflammatory. 13 The oxadiazole pharmacophore has a key property that influences the ability of a drug to reach the target by transmembrane diffusion and show potent antimicrobial activity. 14 Inspired by the above facts and in continuation of an ongoing research program in the field of the synthesis and determination of the antimicrobial activity of medicinally important compounds, 15, 16 the synthesis and antimicrobial evaluation of new oxadiazole derivatives are reported herein.
EXPERIMENTAL

Material and methods
Melting points of the synthesized compounds were determined in open-glass capillaries on Stuart SMP10 melting point apparatus and are uncorrected. The purity of the compounds was checked by thin layer chromatography (TLC). Silica gel, 0.25 mm, 60 GF 254 , precoated sheets obtained from Merck, (Germany) were used for the TLC and the spots were visualized by iodine vapor/ultraviolet light. The IR spectra were obtained on a Perkin-Elmer 1600 FTIR spectrometer in KBr pellets. The 1 H-NMR spectra were recorded in DMSO-d 6 solutions on a Varian-Mercury 300 MHz spectrometer using tetramethylsilane as the internal reference. The 13 C-NMR spectra were recorded in DMSO-d 6 solutions on a Bruker Avance II 400 spectrometer at using tetramethylsilane as the internal reference. The mass spectra were recorded on a Shimadzu GCMS-QP 1000 EX. The elemental analyses were performed on an ECS 4010 elemental combustion system. The necessary chemicals were purchased from Loba Chemie, Fluka and Aldrich.
A mixture of 2-methoxybenzaldehyde (1.36 g, 0.01 mol) and isoniazid (1.37 g, 0.0100 mol) in 15 ml of absolute ethanol was refluxed for 7 h. The completion of reaction was confirmed by TLC. The reaction mixture was then poured into ice-cold water and the obtained precipitate was filtered and dried in an oven at a low temperature. The product was recrystallized from absolute ethanol. 17 Yield 68 %; m.p. 204-207 °C.
isonicotinohydrazide (612 mg, 0.00240 mol) along with (0.10 ml, 0.0036 mol) of formaldehyde and (0.0024 mol) of dimethylamine was placed in 100 ml round bottom flask to which 50 ml of absolute ethanol was added. The pH was adjusted to 4 with hydrochloric acid and the mixture refluxed for 35 h. Completion of the reaction was confirmed by TLC. The reaction mixture was then poured into a beaker and concentrated on a water bath. The reaction mixture was allowed to cool to room temperature and then diethyl ether was added. The reaction mixture was kept for 3-5 h in a refrigerator, filtered and washed with n-hexane. The product was recrystallized from absolute ethanol. Yield 78 %; m.p. 222--225 °C.
1-(2-(3-((Dimethylamino)methyl)-2-methoxyphenyl)-5-(pyridin-4-yl)-1,3,4-oxadiazol--3(2H)-yl)ethanone (3a)
A mixture of (E)-N'-3-((dimethyamino)methyl)-2-methoxybenzylidene)isonicotinohydrazide (3.57 g, 0.0100 mol) with an excess of acetic anhydride was refluxed for 7 h until the completion of the reaction, which was confirmed by TLC. The excess acetic anhydride was distilled off and the residue was poured onto crushed ice. The solid thus obtained was filtered; washed with water and then recrystallized with aqueous methanol. Yield 75 %; m.p. 168-170 °C.
General procedure for synthesis of the substituted oxadiazoles 4a-p
A mixture of 3a (0.010 mol) and an equimolar amount of an appropriate aromatic amine (0.010 mol) was added to 25 ml absolute ethanol with a drop of glacial acetic acid and heated under reflux for 7-9 h. The obtained precipitate was filtered off; washed with ethanol and recrystallized from absolute ethanol to obtain compounds 4a-p.
Antimicrobial activity
The synthesized compounds were evaluated for their in vitro antimicrobial activity against the Gram-positive bacteria Staphylococcus aureus (MTCC 96) and Bacillus subtilis (MTCC 121), the Gram-negative bacteria Escherichia coli (MTCC 40) and Pseudomonas aeruginosa (MTCC 2453) and the fungal strains Candida albicans (MTCC 227) and Aspergillus niger (MTCC 8189). Antimicrobial activity was assessed by the serial two-fold dilution technique. Amoxicillin was used as the standard drug for the antibacterial activity and nystatin was used as the standard drug for the antifungal activity. All the compounds were dissolved in dimethyl sulfoxide to give a concentration of 10 µg ml -1 . The two-fold dilutions of the test and standard compounds were prepared in double strength nutrient broth I.P. (bacteria) or Sabouraud dextrose broth I.P. (fungi). 18 The stock solution was serially diluted to give concentrations of 50-0.78 µg ml -1 in the nutrient broth. The inoculum size was approximately 10 6 colony forming units (CFU ml -1 ). The tubes were incubated at 37±1°C for 24 h (bacteria), 25 °C for C. albicans and 35°C for A. niger for 7 days. Subsequently, the inoculated culture tubes were macroscopically examined for turbidity. The culture tube showing turbidity (lower concentration) and the culture tube showing no turbidity (higher concentration) gave the minimum inhibitory concentration (MIC) for the compound.
RESULTS AND DISCUSSION
The syntheses of the target compounds were performed according to the outline given in Scheme 1. Compounds 4a-p were readily prepared in good yield and purity. Firstly, an equimolar mixture of 2-methoxybenzaldehyde and isonicotinohydrazide was refluxed to form (E)-N'-(2-methoxybenzylidene)isonicotinohydrazide (1a), then its reaction with formaldehyde and dimethylamine formed (E)-N'-(3-((dimethyamino)methyl)-2-methoxybenzylidene)isonicotinohydrazide (2a), which on treatment with acetic anhydride yielded 1-(2-(3-((dimethylamino)methyl)-2-methoxyphenyl)-5-(pyridin-4-yl)-1,3,4-oxadiazol-3(2H)-yl)ethanone (3a) and in the last reaction with substituted aromatic amines, it afforded a series of (Z)-N-(1-(2-(3-((dimethylamino)methyl)-2-methoxyphenyl)-5-(pyridin-4-yl)--1,3,4-oxadiazol-3(2H)-yl)ethylidene)benzenamine derivatives (4a-p). The structure, melting points and yields the synthesized compounds 4a-p are given in Table I . The purity of the compounds was checked by TLC and elemental analyses. Nevertheless, the structures of all new compounds synthesized were confirmed by IR, 1 H-NMR and 13 C-NMR spectroscopy. The analytic and spectral data for all the compounds synthesized in this study are given in the Supplementary material to this paper. The IR spectra of all the compounds 4a-p showed absorption bands at around 2993-2955, 2868-2839, 1679-1664, 1589-1557, 1189--1174, 1097-1018 cm -1 regions, confirming the presence of CH, CH 2 , C=N, C=C, C-N, C-O groups, respectively. The, the chemical shifts, multiplicities, and coupling constants of the signals in the 1 H-NMR spectra of the respective derivatives 4a-p verified their structures. The spectra of most compounds showed the characteristic 4H protons of pyridine at around δ 8.98-8.15 ppm, the characteristic protons of phenyl at δ 7.95-6.45 ppm, the 1H proton of oxadiazole at around δ 5.73-5.37 ppm, the 3H protons of O-CH 3 at around δ 3.88-3.64 ppm, the 2H protons of Ar-CH 2 -N at around δ 3.69-3.52 ppm, the 6H protons of N-2CH 3 at around δ 2.49-2.26 ppm and the 3H protons of CH 3 at δ 1. 
Antimicrobial activity
The compounds were evaluated for their antimicrobial properties in comparison to the control antibacterial drug amoxicillin and antifungal drug nystatin. The determined MIC values of compounds 4a-p are listed in Table II . The investigation of antibacterial screening data revealed that all the tested compounds 14 MALHOTRA et al. showed moderate to good bacterial inhibition. The compounds 4g, 4h, 4m and 4p displayed excellent activity against the Gram-positive bacteria B. subtilis and S. aureus and good activity against the Gram-negative bacteria P. aeruginosa and E. coli. Compounds 4c, 4d and 4f showed moderate antibacterial activity, while compounds 4a, 4b, 4e and 4o were less active against the tested bacterial strains. Of all the synthesized derivatives, compound 4a was found to be the least active compound against most of the bacterial strain. From, these results, it could be generalized that the p-chloro-, o-bromo-, p-nitro-and p-methoxy-substituted oxadiazole derivatives showed higher antibacterial activity compared to the other analogues. Concerning the antifungal activity of the tested compounds, only two fungal strains were selected C. albicans and A. niger and the result of antifungal screening data revealed that all the synthesized compounds showed variable degrees of inhibition against the tested fungi. The investigation of antibacterial screening data revealed that all the tested compounds showed moderate to good fungal inhibition as compare to standard drug nystatin. Of the screened compounds, 4g, 4h, 4m and 4p exhibited the highest antifungal activity against both fungal strains, while compounds 4e, 4l and 4n showed moderate antifungal activity. Among all the synthesized derivatives, compound 4i was found to be the least active com-
